A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Artios Pharma Ltd
Artios Pharma Ltd
National Cancer Institute (NCI)
Frontier Medicines Corporation
Beijing Biotech
PMV Pharmaceuticals, Inc
Mayo Clinic
Verastem, Inc.
M.D. Anderson Cancer Center
Aulos Bioscience, Inc.
Essen Biotech
Essen Biotech
DualityBio Inc.
Second Life Therapeutics
Ocellaris Pharma, Inc.
VM Oncology, LLC
Takeda
Liaoning Medical Diagnosis and Treatment Technology Research and Development Co., Ltd.
Sotio Biotech Inc.
Revolution Medicines, Inc.
Vedanta Biosciences, Inc.
Eisai Inc.
Mirati Therapeutics Inc.
7 Hills Pharma, LLC
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
GI Innovation, Inc.
Verastem, Inc.
Incyte Corporation
Yuhan Corporation
NuCana plc
Hutchmed
Imugene Limited
iOnctura
PureTech
NextCure, Inc.
M.D. Anderson Cancer Center
GI Innovation, Inc.
Salubris Biotherapeutics Inc
BioNTech SE
NantCell, Inc.
NantCell, Inc.
NextCure, Inc.
NextCure, Inc.
Roswell Park Cancer Institute
Nektar Therapeutics
Nektar Therapeutics
Institut Bergonié
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
St. Olavs Hospital
NKGen Biotech, Inc.
Chinese PLA General Hospital